July 04, 2025

Respiratory Disease: From Scarcity to Solutions

How low-resource-focused innovations in biomarker diagnostics are shaping the future of global health

The Pathologist

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 18, 2025

NCCN Clinical Practice Guidelines in Oncology: 2025 Updates

The National Comprehensive Cancer Network (NCCN) released its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, covering eight tumor types. Today, guidelines are availa...

The ASCO Post

June 17, 2025

Proposed Budget Cuts to Medicaid May Result in More Than 16,500 Medically Preventable Deaths Annually

The enactment of the proposed budget bill making its way through Congress, which includes major cuts to Medicaid, could increase the number of uninsured Americans by 7.6 million and the number of medi...

The ASCO Post

June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

October 29, 2024

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

May 07, 2025

Cystic Fibrosis: New Evidence-Based Guidelines for Newborn Screening

New Cystic Fibrosis Foundation guidelines aim to improve consistency, equity, and accuracy in CF newborn screening nationwide.

Conexiant

October 31, 2024

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

Withdrawing aspirin one month after PCI in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared to dual antiplatelet therapy, the current standard of care.

Mount Sinai New York